Our next congress

INCIT congress 24′

Congrès Incit 24′

Immunology and New Concepts in Immunotherapy

This second edition of the INCIT congress aims to review the latest developments in the identification of new cell therapy targets and strategies, recent advances in immunomodulation and therapeutic targeting in cancer, infectious and inflammatory diseases, by leading researchers in these fields and by INCIT researchers.

Place

Faculté de pharmarcie à Nantes (9 rue Bias – 44000, FR) Salle : amphithéâtre

Dates & Timetables

Thursday June 13th, 2024 @ 12:00
Friday, June 14th, 2024 @ 17:00

Prices

Early birds (until April  30 2024)

90 € for students
170 € for researchers

Registration fee (after May 1st 2024)

130 € for students
220 € for researchers

Abstract submission

You can complete the following form and send it to valerie.pecqueret@univ-nantes.fr

Deadline : 15 April 2024 !

Abstract submission

Invited speakers

Program

Thursday, June 13th, 2024

 

12:00 • Welcome lunch

13:00 • Meeting introduction / INCIT Overview – Frédéric Altare, PhD – INCIT, Nantes, France

13:30 • KeynoteDan Littman, MD/PhD – NYU (HHMI), USA – « Title to be announced »

 

Session # 1 New targets & strategies for cell therapies (Chairmen/women : to be announced)

14:30 • Else Marit Inderberg, PhD – Oslo University Hospital, Norway – « TCR- and CAR-modified T cells for solid cancer treatment »

15:00 • 1 Selected short talk

15:15 • Coffee break & Poster session

15:45 • Sebastian Amigorena, PhD – Institut Curie, France – « Epigenetic control of anti-tumor immune responses »

16:15 • 1 Selected short talk

16:30 • Catherine Rabu, PharmD, PhD –  INCIT, Nantes, France – « Antigen identification for melanoma immunotherapy: peptides derived from long non-coding RNA »

17:00 • 1 Selected short talk

 

19:15 • Cocktail buffet

 

Friday June 14th 2024

Session # 2  Immuno-modulation / Immuno-inflammation (Chairmen/women : to be announced)

09:00 • Gérard Eberl, PhD – Pasteur Institute, Paris France
« Regulation of hypothalamic functions by microbiota and theimmune system »

09:30 • 1 Selected short talk

09:45 • Julie Blander, PhD – Weill Cornell Medicine – Jill Roberts Inst. for Research in Inflammatory Bowel Disease NY, USA
« To be continued »

10:15 • Coffee break & Poster session

10:45 • Emmanuelle Godefroy, PhD – INCIT, Nantes, France.
« Human Microbiota-Reactive DP8a Regulatory T Cells In Health and Gut-related Disorders »

11:15 • 2 Selected short talk

12:00 • Lunch

Session # 3 Therapeutic targeting (Chairmen/Women : to be announced)

13:30 • Ferry Ossendorp, PhD – Leiden University, The Netherlands – « Self-adjuvanted peptide cancer vaccines »

14:00 • Najma Rachidi, PhD – Institut Pasteur, Paris, France – « Title to be announced »

14:30 • 1 Selected short talk

14.45 • Coffee break & Poster session

15:15 • 1 Selected short talk

15:30 • Blandine Monel, PhD – INCIT, Nantes, France
« Title to be announced »

16:00 • Sophie Lucas, MD, PhD – UCL, Brussels, Belgium – « Harnessing the pleiotropy of TGF-ß cytokines to treat diseases associated with immune dysfunction »

16:30 • Meeting conclusion – Frédéric Altare, PhD – INCIT, Nantes, France

Sponsors

Logo SFR bonamy

Contact organizer

Event coordinator : Valérie Pecqueret • valerie.pecqueret@univ-nantes.fr

How to reach venue ?

Incit congress in pictures